NCT06612879View on ClinicalTrials.gov

A Study to Find Out How BIIB141 (Omaveloxolone) Moves From the Blood Into the Breastmilk of Healthy Women Who Are Breastfeeding or Pumping Milk

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 18, 2024

Primary Completion Date

March 11, 2025

Study Completion Date

April 8, 2025

Conditions
Healthy Volunteer
Interventions
DRUG

Omaveloxolone

Administered as specified in the treatment arm.

Trial Locations (1)

53704

Fortrea Madison WI, CRU, Madison

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY

NCT06612879 - A Study to Find Out How BIIB141 (Omaveloxolone) Moves From the Blood Into the Breastmilk of Healthy Women Who Are Breastfeeding or Pumping Milk | Biotech Hunter | Biotech Hunter